Small cell carcinoma of the prostate

Diagnostic Histopathology

Volumn 14, Issue 3, 2008, Pages 117-121

  Yao, Jorge L ^a,b   Huang, Jiaoti ^a,b   Anthony di Sant'Agnese, P ^a,b  

^a Laboratory Medicine ^*  (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

immunohistochemistry; neuroendocrine tumors; prostate; prostate carcinoma; small cell carcinoma

Indexed keywords

BOMBESIN; CALCITONIN; CD56 ANTIGEN; CHROMOGRANIN A; CISPLATIN; CYTOKERATIN; ETOPOSIDE; PROSTATE SPECIFIC ANTIGEN; SOMATOSTATIN; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER SURVIVAL; DIFFERENTIAL DIAGNOSIS; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SMALL CELL CARCINOMA;

EID: 41549153858     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2008.02.005     Document Type: Article

References (44)

1. Wenk R.E., Bhagavan B.S., Levy R., Miller D., and Weisburger W. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer 40 2 (1977) 773-778
2. Haider K., Shahid R.K., Finch D., et al. Extrapulmonary small cell cancer: a Canadian province's experience. Cancer 107 9 (2006) 2262-2269
3. Abbas F., Civantos F., Benedetto P., and Soloway M.S. Small cell carcinoma of the bladder and prostate. Urology 46 5 (1995) 617-630
4. Tetu B., Ro J.Y., Ayala A.G., Johnson D.E., Logothetis C.J., and Ordonez N.G. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer 59 10 (1987) 1803-1809
5. Oesterling J.E., Hauzeur C.G., and Farrow G.M. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J Urol 147 3 Pt 2 (1992) 804-807
6. Helpap B., and Kollermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Virchows Arch 434 5 (1999) 385-391
7. Christopher M.E., Seftel A.D., Sorenson K., and Resnick M.I. Small cell carcinoma of the genitourinary tract: an immunohistochemical, electron microscopic and clinicopathological study. J Urol 146 2 (1991) 382-388
8. Yao J.L., Madeb R., Bourne P., et al. Small cell carcinoma of the prostate: an immunohistochemical study. Am J Surg Pathol 30 6 (2006) 705-712
9. Moore S.R., Reinberg Y., and Zhang G. Small cell carcinoma of prostate: effectiveness of hormonal versus chemotherapy. Urology 39 5 (1992) 411-416
10. Steineck G., Reuter V., Kelly W.K., Frank R., Schwartz L., and Scher H.I. Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements. Acta Oncol 41 7-8 (2002) 668-674
11. Papandreou C.N., Daliani D.D., Thall P.F., et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20 14 (2002) 3072-3080
12. Yashi M., Terauchi F., Nukui A., et al. Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review. Urol Oncol 24 4 (2006) 313-317
13. Rubenstein J.H., Katin M.J., Mangano M.M., et al. Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol 20 4 (1997) 376-380
14. Sim S.J., Glassman A.B., Ro J.Y., Lee J.J., Logothetis C.J., and Liu F.J. Serum calcitonin in small cell carcinoma of the prostate. Ann Clin Lab Sci 26 6 (1996) 487-495
15. Tanaka M., Suzuki Y., Takaoka K., et al. Progression of prostate cancer to neuroendocrine cell tumor. Int J Urol 8 8 (2001) 431-436 discussion 437
16. Aygun C. Small cell carcinoma of the prostate: a case report and review of the literature. Md Med J 46 7 (1997) 353-356
17. Venkatesh P.K., Motwani B., Sherman N., et al. Metastatic pure small-cell carcinoma of prostate. Am J Med Sci 328 5 (2004) 286-289
18. Erasmus C.E., Verhagen W.I., Wauters C.A., and van Lindert E.J. Brain metastasis from prostate small cell carcinoma: not to be neglected. Can J Neurol Sci 29 4 (2002) 375-377
19. Matschke J., and Erbersdobler A. Extensive cerebral metastases from neuroendocrine carcinoma of the prostate. Virchows Arch 444 2 (2004) 202-203
20. Epstein J.I., Allsbrook Jr. W.C., Amin M.B., and Egevad L.L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 9 (2005) 1228-1242
21. Ro J.Y., Tetu B., Ayala A.G., and Ordonez N.G. Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases. Cancer 59 5 (1987) 977-982
22. Okada H., Gotoh A., Ogawa T., Arakawa S., Ohbayashi C., and Kamidono S. Two cases of small cell carcinoma of the prostate. Scand J Urol Nephrol 30 6 (1996) 503-508
23. Bostwick D.G., Iczkowski K.A., Amin M.B., Discigil G., and Osborne B. Malignant lymphoma involving the prostate: report of 62 cases. Cancer 83 4 (1998) 732-738
24. Cheuk W., Kwan M.Y., Suster S., and Chan J.K. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 125 2 (2001) 228-231
25. Kaufmann O., and Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 36 5 (2000) 415-420
26. Huang J., Yao J.L., and di Sant'Agnese P.A. Neuroendocrine differentiation in prostate cancer. In: Kirby R., Partin A., Feneley M., and Parsons J.K. (Eds). Prostate cancer: principles and practice. 1st edn (2006), Taylor and Francis Medical Books, Abdington 143-150
27. Huss W.J., Gray D.R., Werdin E.S., Funkhouser Jr. W.K., and Smith G.J. Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model. Prostate 60 2 (2004) 77-90
28. Pardal R., Clarke M.F., and Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3 12 (2003) 895-902
29. Smalley M., and Ashworth A. Stem cells and breast cancer: A field in transit. Nat Rev Cancer 3 11 (2003) 832-844
30. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 6859 (2001) 105-111
31. Clegg N., Ferguson C., True L.D., et al. Molecular characterization of prostatic small-cell neuroendocrine carcinoma. Prostate 55 1 (2003) 55-64
32. Kaplan-Lefko P.J., Chen T.M., Ittmann M.M., et al. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55 3 (2003) 219-237
33. Kasper S., and Smith Jr. J.A. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer. J Urol 172 1 (2004) 12-19
34. Masumori N., Thomas T.Z., Chaurand P., et al. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res 61 5 (2001) 2239-2249
35. van Bokhoven A., Varella-Garcia M., Korch C., et al. Molecular characterization of human prostate carcinoma cell lines. Prostate 57 3 (2003) 205-225
36. Okada H., Shirakawa T., Miyake H., et al. Establishment of a prostatic small-cell carcinoma cell line (SO-MI). Prostate 56 3 (2003) 231-238
37. Kim C.J., Kushima R., Okada Y., and Seto A. Establishment and characterization of a prostatic small-cell carcinoma cell line (PSK-1) derived from a patient with Klinefelter syndrome. Prostate 42 4 (2000) 287-294
38. Pinthus J.H., Waks T., Schindler D.G., et al. WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma. Cancer Res 60 23 (2000) 6563-6567
39. True L.D., Buhler K., Quinn J., et al. A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49. Am J Pathol 161 2 (2002) 705-715
40. Randolph T.L., Amin M.B., Ro J.Y., and Ayala A.G. Histologic variants of adenocarcinoma and other carcinomas of prostate: pathologic criteria and clinical significance. Mod Pathol 10 6 (1997) 612-629
41. Kurt E., Sezgin C., Evrensel T., et al. Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma. Int J Clin Pract 59 5 (2005) 537-543
42. Lonardo F., Pass H.I., and Lucas D.R. Immunohistochemistry frequently detects c-Kit expression in pulmonary small cell carcinoma and may help select clinical subsets for a novel form of chemotherapy. Appl Immunohistochem Mol Morphol 11 1 (2003) 51-55
43. Micke P., Basrai M., Faldum A., et al. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications. Clin Cancer Res 9 1 (2003) 188-194
44. Pan C.X., Yang X.J., Lopez-Beltran A., et al. c-kit expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol (2004)